ALLIANCEBERNSTEIN L.P. - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2016$19,000
-29.6%
77,7000.0%0.00%
Q4 2015$27,000
-80.3%
77,700
-1.2%
0.00%
Q3 2015$137,000
-21.7%
78,6240.0%0.00%
Q2 2015$175,000
+136.5%
78,624
+105.2%
0.00%
Q1 2015$74,0000.0%38,324
+37.7%
0.00%
Q4 2014$74,000
-36.2%
27,824
-27.8%
0.00%
Q3 2014$116,000
+18.4%
38,524
+61.0%
0.00%
Q2 2014$98,000
-50.0%
23,924
-47.4%
0.00%
Q1 2014$196,000
-22.8%
45,445
-6.3%
0.00%
Q4 2013$254,000
-36.8%
48,524
-23.8%
0.00%
Q3 2013$402,000
-33.8%
63,667
-47.7%
0.00%
-100.0%
Q2 2013$607,000121,7070.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2014
NameSharesValueWeighting ↓
CAXTON CORP 37,061,186$82,646,00087.47%
Geller Advisors LLC 187,323$418,0000.24%
IRONWOOD INVESTMENT MANAGEMENT LLC 430,749$961,0000.22%
Verity Asset Management, Inc. 81,694$182,0000.16%
CAXTON CORP 52,000$116,0000.12%
Catalyst Capital Advisors LLC 400,000$892,0000.10%
Cutler Capital Management, LLC 72,500$161,0000.07%
STONERIDGE INVESTMENT PARTNERS LLC 239,202$533,0000.07%
SECOR Capital Advisors, LP 35,087$78,0000.03%
Roundview Capital LLC 29,100$65,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders